Mariëlle J. Stam

Mariëlle J. Stam

Auto-generated profile, based on publicly available information

Mariëlle J. Stam

Department of Neurology, Amsterdam University Medical Center, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2025 in Journal of Neural Engineering
Verified
Journal Article
Open access
BSBart Swinnen
Bart Swinnen
ABArthur W G Buijink
Arthur W G Buijink
MSMariëlle J Stam
Mariëlle J Stam
DHDeborah Hubers
Deborah Hubers
MNMartijn de Neeling
Martijn de Neeling
MBMartijn Beudel
Martijn Beudel
Objective. Local field potential (LFP) recordings using chronically implanted sensing-enabled stimulators are a powerful tool for indexing symptom presence and severity in neurological and neuropsychiatric disorders, and for enhancing our neurophysiological understanding of brain processes. LFPs have gained interest as input signals for closed-loop deep brain stimulation (DBS) and can be used to inform DBS parameter selection. LFP recordings using chronically implanted sensing-enabled stimulators have various implementational challenges. Approach. Here we describe our collective experience using BrainSense (Medtronic®) for clinical and research work. We aim to provide insightful tips and practical advice to empower readers with the knowledge needed to navigate the intricacies of the device and make the most out of its features. Main results. The central issues that apply to several BrainSense features encompass restricted compatibility of stimulation configuration with sensing, differences in electrophysiological signal properties between ‘stimulation OFF’ and ‘stimulation ON at 0.0 mA’, and challenges associated with the internal clock of the neurostimulator. In addition, since recordings are obtained from bipolar and not monopolar channels, spatial certainty regarding the distribution of LFPs around the DBS electrode is limited. Several options exist to synchronize LFP time series with external data streams, but standardization and generalization are lacking. The use of at-home chronic LFP recording is limited by a low temporal and spectral resolution. Regarding at-home LFP snapshots, LFP time series are not stored, parts of the power spectrum are censored when stimulating at high or low frequencies, and the stimulation amplitude is not readily available. Significance. We discussed practical applications, implementation, system limitations, and pitfalls with the aim that sensing can be better applied for clinical practice and research.

10 July 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
MSMariëlle J. Stam
Mariëlle J. Stam
BWBernadette C. M. van Wijk
Bernadette C. M. van Wijk
ABArthur W. G. Buijink
Arthur W. G. Buijink
DPDan Piña-Fuentes
Dan Piña-Fuentes
RBRob M. A. de Bie
Rob M. A. de Bie
MBMartijn Beudel
Martijn Beudel
Beta oscillations (±13–35 Hz) and aperiodic spectral features extracted from local field potential (LFP) recordings have been identified as promising physiomarkers for adaptive deep brain stimulation (aDBS) in Parkinson’s disease. However, the long-term consistency of these signal features across behavioural and clinical conditions remains unclear. Bilateral subthalamic nucleus LFPs were recorded from twelve patients with an average inter-recording interval of 137 days, during rest, a finger-to-nose task and speech, with stimulation switched off and on. Intra-class correlation coefficients indicated moderate between-visit consistency for aperiodic offset and exponent but good to excellent consistency of beta peak power. Most aperiodic and power changes induced by task execution and stimulation were statistically comparable across visits. Results remained inconclusive regarding the properties of beta peaks exhibiting the strongest power suppression post-stimulation. Our findings support the potential of beta peak power as primary physiomarker for aDBS, with aperiodic components as possibly suitable supplementary markers.

16 May 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
MSMariëlle J Stam
Mariëlle J Stam
MNMartijn G J de Neeling
Martijn G J de Neeling
BKBart J Keulen
Bart J Keulen
DHDeborah Hubers
Deborah Hubers
RBRob M A de Bie
Rob M A de Bie
MBMartijn Beudel
Martijn Beudel
Introduction Deep brain stimulation (DBS) is a proven effective treatment for Parkinson’s disease (PD). However, titrating DBS stimulation parameters is a labourious process and requires frequent hospital visits. Additionally, its current application uses continuous high-frequency stimulation at a constant intensity, which may reduce efficacy and cause side effects. The objective of the AI-DBS study is to identify patient-specific patterns of neuronal activity that are associated with the severity of motor symptoms of PD. This information is essential for the development of advanced responsive stimulation algorithms, which may improve the efficacy of DBS. Methods and analysis This longitudinal prospective observational cohort study will enrol 100 patients with PD who are bilaterally implanted with a sensing-enabled DBS system (Percept PC, Medtronic) in the subthalamic nucleus as part of standard clinical care. Local neuronal activity, specifically local field potential (LFP) signals, will be recorded during the first 6 months after DBS implantation. Correlations will be tested between spectral features of LFP data and symptom severity, which will be assessed using (1) inertial sensor data from a wearable smartwatch, (2) clinical rating scales and (3) patient diaries and analysed using conventional descriptive statistics and artificial intelligence algorithms. The primary objective is to identify patient-specific profiles of neuronal activity that are associated with the presence and severity of motor symptoms, forming a ‘neuronal fingerprint’. Ethics and dissemination Ethical approval was granted by the local ethics committee of the Amsterdam UMC (registration number 2022.0368). Study findings will be disseminated through scientific journals and presented at national and international conferences.

30 October 2024 in Movement Disorders
Verified
Journal Article
Open access
DHDeborah Hubers
Deborah Hubers
LHLarissa R. Heideman
Larissa R. Heideman
MSMariëlle J. Stam
Mariëlle J. Stam
JDJoke M. Dijk
Joke M. Dijk
PSP. Rick Schuurman
P. Rick Schuurman
MBMartijn Beudel
Martijn Beudel

17 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MSM.J. Stam
M.J. Stam
BWBernadette C.M. Van Wijk
Bernadette C.M. Van Wijk
PSP. Sharma
P. Sharma
MBM. Beudel
M. Beudel
DPD.A. Piña-Fuentes
D.A. Piña-Fuentes
ABArthur Buijink
Arthur Buijink
Objective: Sensing-enabled neurostimulators for deep brain stimulation (DBS) therapy record neural activity directly from the stimulating electrodes in the form of local field potentials (LFPs). However, these LFPs are often contaminated with electrocardiographic (ECG) artifacts that impede the detection of physiomarkers for adaptive DBS research. This study systematically compared the ability of different ECG suppression methods to recover disease-specific electrical brain activity from ECG-contaminated LFPs. Approach: Three ECG suppression methods were evaluated: (1) QRS interpolation of the Perceive toolbox, (2) four variants of a template subtraction method, and (3) sixteen variants of a singular value decomposition (SVD) method. The performance of these methods was examined using LFPs recorded with the Medtronic PerceptTM PC system from the subthalamic nucleus in nine patients with Parkinson’s disease while stimulation was turned off (“OFF-DBS”; anode disconnected) and while stimulation was turned on at 0 mA (“ON-DBS 0 mA”; anode connected). In addition, ECG-contaminated LFPs were simulated by scaling a co-recorded external ECG signal and adding it to the OFF-DBS LFPs. Main Results: ECG artifacts were present in 10 out of 18 ON-DBS 0 mA recordings. All ECG suppression methods were able to drastically reduce the percent difference of beta band (13 – 35 Hz) spectral power and at least partly recover the beta peak and beta burst dynamics. Using predetermined R-peaks improved the performance of the ECG suppression methods. Lengthening the time window around the R-peaks resulted in stronger reduction in artifact-induced beta band power but at an increased risk of flattening the beta peak and loss of beta burst dynamics. Significance: The SVD method formed the preferred trade-off between artifact cleaning and signal loss, as long as its parameter settings (time window around the R-peaks; number of components) are adequately chosen.

11 August 2026 in Brain Stimulation
Verified
Journal Article
Open access
YWY. Wiggerts
Y. Wiggerts
PSP.R. Schuurman
P.R. Schuurman
MSM.J. Stam
M.J. Stam
DHD. Hubers
D. Hubers
BKB.J. Keulen
B.J. Keulen
MBM. Bot
M. Bot